Meet the Expert Session

Predicting Payer Uptake with Precision

When and how to select the right analogs to set the most accurate expectations and payer strategy at launch.

Summary:

  • What are the metrics that payers use to evaluate newly launched drugs?
  • Using those metrics, how can manufacturers select an ideal analog from the vast historical launch data that Analytics + PAR provides, to most closely and accurately predict payers’ anticipated adoption of a new drug?
  • How can users overlay New to Market policies over analog data to precisely segment slow restrictive payers from fast non-restrictive payers at launch?

View the recording of this past Meet the Expert session today!



Meet the Expert Session

Predicting Payer Uptake with Precision

When and how to select the right analogs to set the most accurate expectations and payer strategy at launch.

Summary:

  • What are the metrics that payers use to evaluate newly launched drugs?
  • Using those metrics, how can manufacturers select an ideal analog from the vast historical launch data that Analytics + PAR provides, to most closely and accurately predict payers’ anticipated adoption of a new drug?
  • How can users overlay New to Market policies over analog data to precisely segment slow restrictive payers from fast non-restrictive payers at launch?

Tuesday, April 6th, 1:00-2:00pm ET

Register for MMIT’s Meet the Expert session today!



Our Experts

Carolyn Zele

Senior Solution Consultant

Carolyn Zele has been a solution consultant with MMIT for the last five years helping pharmaceutical manufacturers simplify market access and prepare for launch success. Prior to MMIT, Carolyn spent numerous years in the payer/PBM space managing formulary teams and technology across both regulated and non-regulated lines of business. Each day she taps into her 17+ years of industry experience to help MMIT clients navigate and solve their market access challenges.

Ritupriya Yamujala

Senior Solution Consultant

Ritupriya Yamujala has a molecular biology research background and graduated from Rutgers University with a Master of Business and Science in Biotechnology and Genomics. She has 8+ years of extensive experience developing market research products and providing consultation to solve pharmaceutical manufacturers’ critical business questions. Most recently, she uses her indication-specific market knowledge and expertise to align companies with solutions that would best meet their new drug launch and sustained coverage placement goals.

Carolyn Zele

Senior Solution Consultant

Carolyn Zele has been a solution consultant with MMIT for the last five years helping pharmaceutical manufacturers simplify market access and prepare for launch success. Prior to MMIT, Carolyn spent numerous years in the payer/PBM space managing formulary teams and technology across both regulated and non-regulated lines of business. Each day she taps into her 17+ years of industry experience to help MMIT clients navigate and solve their market access challenges.

Ritupriya Yamujala

Senior Solution Consultant

Ritupriya Yamujala has a molecular biology research background and graduated from Rutgers University with a Master of Business and Science in Biotechnology and Genomics. She has 8+ years of extensive experience developing market research products and providing consultation to solve pharmaceutical manufacturers’ critical business questions. Most recently, she uses her indication-specific market knowledge and expertise to align companies with solutions that would best meet their new drug launch and sustained coverage placement goals.